Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMTNASDAQ:BBLGOTCMKTS:BNKLNASDAQ:NAOV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00$0.00▼$0.00N/A1.56N/AN/ABBLGBone Biologics$5.91+11.5%$4.63$3.42▼$25.50$3.22M0.75236,942 shs83,376 shsBNKLBionik Laboratories$0.00$0.00▼$0.00N/AN/AN/AN/ANAOVNanovibronix$0.92-3.6%$2.96$0.67▼$16.25$2.38M1.761.60 million shs328,279 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%-33.33%-33.33%BBLGBone Biologics0.00%+24.82%+17.26%+11.93%-33.89%BNKLBionik Laboratories0.00%0.00%0.00%0.00%-99.90%NAOVNanovibronix0.00%-9.80%-15.60%-79.04%-88.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ABBLGBone Biologics1.0138 of 5 stars0.05.00.00.01.20.01.3BNKLBionik LaboratoriesN/AN/AN/AN/AN/AN/AN/AN/ANAOVNanovibronix0.0579 of 5 stars0.02.00.00.00.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/ABBLGBone Biologics 0.00N/AN/AN/ABNKLBionik Laboratories 0.00N/AN/AN/ANAOVNanovibronix 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270KN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/A$8.39 per shareN/ABNKLBionik Laboratories$1.80MN/AN/AN/AN/AN/ANAOVNanovibronix$2.56M0.93N/AN/A$1.84 per share0.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00∞N/AN/AN/AN/AN/ABBLGBone Biologics-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)BNKLBionik Laboratories-$4.95MN/A0.00N/AN/AN/AN/AN/AN/ANAOVNanovibronix-$3.70M-$13.53N/A∞N/A-210.82%-54.73%-38.63%8/13/2025 (Estimated)Latest BBLG, ABMT, NAOV, and BNKL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025NAOVNanovibronixN/A-$3.98N/A-$3.98N/A$1.02 million5/12/2025Q1 2025BBLGBone Biologics-$2.88-$1.92+$0.96-$0.32N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/AN/ABNKLBionik LaboratoriesN/AN/AN/AN/AN/ANAOVNanovibronixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMTAdvanced Biomedical TechnologiesN/AN/AN/ABBLGBone BiologicsN/A12.6012.60BNKLBionik LaboratoriesN/AN/AN/ANAOVNanovibronixN/A0.470.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/ABBLGBone Biologics34.30%BNKLBionik LaboratoriesN/ANAOVNanovibronix16.39%Insider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%BBLGBone Biologics7.50%BNKLBionik Laboratories40.37%NAOVNanovibronix7.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableBBLGBone Biologics2550,000504,000Not OptionableBNKLBionik Laboratories10N/AN/ANot OptionableNAOVNanovibronix202.58 million2.40 millionNot OptionableBBLG, ABMT, NAOV, and BNKL HeadlinesRecent News About These CompaniesENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance SystemJune 11, 2025 | finance.yahoo.comNanoVibronix appoints new CEO after acquisitionJune 5, 2025 | uk.investing.comNanoVibronix Appoints Doron Besser As Chief Executive OfficerJune 5, 2025 | nasdaq.comNanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’June 4, 2025 | msn.comNanoVibronix Announces CEO TransitionJune 4, 2025 | finance.yahoo.comNanoVibronix refutes false stock offering claimsMay 30, 2025 | investing.comNanoVibronix Responds to False PostMay 28, 2025 | businesswire.comMajor Louisiana Hospital Selects ENvue System for Feeding Tube ProceduresMay 28, 2025 | finance.yahoo.comNanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and WarrantsMay 16, 2025 | businesswire.comNanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and WarrantsMay 15, 2025 | finance.yahoo.comNanoVibronix Announces Results from UroShield™ Case SeriesMay 12, 2025 | businesswire.comNanoVibronix Regains Nasdaq ComplianceApril 11, 2025 | finance.yahoo.comNanoVibronix, Inc.April 11, 2025 | cnn.comNanoVibronix announces board member resignationApril 5, 2025 | uk.investing.comNanoVibronix renews, expands exclusive distribution agreement with DukehillApril 3, 2025 | markets.businessinsider.comNanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in AustraliaApril 1, 2025 | finance.yahoo.comWhy Nanovibronix Inc. (NAOV) Surged On Thursday?March 21, 2025 | msn.comNanoVibronix Stock Short Interest Report | NASDAQ:NAOV | BenzingaMarch 18, 2025 | benzinga.comNanoVibronix Stock Price, Quotes and Forecasts | NASDAQ:NAOV | BenzingaMarch 18, 2025 | benzinga.comNanoVibronix announces UroShield health service study data publishedMarch 14, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBLG, ABMT, NAOV, and BNKL Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMT$0.0004 0.00 (0.00%) As of 06/20/2025Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.Bone Biologics NASDAQ:BBLG$5.91 +0.61 (+11.51%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$5.86 -0.05 (-0.93%) As of 06/20/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Bionik Laboratories OTCMKTS:BNKLBionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.Nanovibronix NASDAQ:NAOV$0.92 -0.03 (-3.61%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.90 -0.02 (-1.63%) As of 06/20/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
